Experience

Davis Polk advised Pernix Therapeutics Holdings, Inc. in connection with the sale of substantially all of its assets to Currax Holdings LLC, an entity formed by affiliates of Highbridge…

Davis Polk is advising Pernix Therapeutics Holdings, Inc. in connection with its restructuring under chapter 11 of the United States Bankruptcy Code, entry into a “stalking horse” asset…

Davis Polk advised an ad hoc group of Ultra Petroleum Corp. noteholders in connection with a private notes exchange. Under the exchange transaction, the members of the group exchanged…

Davis Polk advised an ad hoc group of holders of 7.785% senior notes due 2017, 9.50% senior notes due 2018 and 9.875% senior notes due 2020, in connection with the successful chapter 11…

Davis Polk is advising the administrative agent in connection with the debtor-in-possession financing facility for iHeartMedia, Inc. and certain of its subsidiaries. The DIP facility…

Davis Polk is advising the Ad Hoc Group of GenOn Energy, Inc. noteholders on the approximately $390.3 million sale of Canal Units 1 and 2 to an affiliate of Stonepeak Infrastructure…

Davis Polk is advising the Ad Hoc Group of GenOn Energy, Inc. noteholders on the approximately $520 million disposition by a subsidiary of GenOn of the Hunterstown power generation facility…

Davis Polk advised the joint lead arrangers, joint bookrunners and the joint co-managers with respect to a $2.925 billion senior secured first-lien term loan facility provided to…

Davis Polk is advising the joint lead arrangers, joint bookrunners and joint co-managers with respect to a $2.425 billion senior secured term loan facility and a $300 million secured…

Davis Polk is advising the administrative agent, collateral agent, joint lead arranger and bookrunner in connection with a $2.3 billion ABL/FILO debtor-in-possession financing facility for…